Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
2006 Standout
Induction of heme oxygenase 1 by Ginkgo biloba in neuronal cultures and potential implications in ischemia.
2002
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Understanding adolescence as a period of social–affective engagement and goal flexibility
2012 Standout
Inflammation and Alzheimer's disease
2000 Standout
The Mellow Years?: Neural Basis of Improving Emotional Stability over Age
2006
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
2001
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Delirium in elderly people
2013 Standout
Large-scale brain networks in cognition: emerging methods and principles
2010 Standout
Updating P300: An integrative theory of P3a and P3b
2007 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Alzheimer's disease
2011 Standout
Mild Cognitive Impairment
2011 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
The neurobiology of zinc in health and disease
2005 Standout
Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases
2015
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis
1998
Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts
1998
The utility of neurophysiological markers in the study of alcoholism
2005
Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons
2008
Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer’s disease — a target for neuroprotective treatment strategies?
2002
EEG dynamics in patients with Alzheimer's disease
2004
Epidemiological Dementia Index: A Screening Instrument for Alzheimer’s Disease and Other Types of Dementia Suitable for Use in Populations with Low Education Level
1998
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Genetics of human prefrontal function
2003
Neurochemical Substrates and Neuroanatomical Generators of the Event-Related P300
1999
MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies
2017
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.
1998
Localization and Cell Association of C1q in Alzheimer's Disease Brain
1996
β-Amyloid converts an acute phase injury response to chronic injury responses
1996
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Alzheimer's disease
2006 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Alzheimer's Disease
2010 Standout
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease
2006
Sterile inflammation: sensing and reacting to damage
2010 Standout
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Small vessel disease: mechanisms and clinical implications
2019 Standout
Blood-Brain Barrier Permeability Correlates with Medial Temporal Lobe Atrophy but Not with Amyloid-β Protein Transport across the Blood-Brain Barrier in Alzheimer’s Disease
2007
Alzheimer's Disease
2004 Standout
Neurodegenerative diseases and oxidative stress
2004 Standout
Variability in Annual Mini-Mental State Examination Score in Patients With Probable Alzheimer Disease
1999
The Pathobiology of Vascular Dementia
2013 Standout
Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease
2002
Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging
2008
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
2008 Standout
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Effects of Ginkgo biloba in dementia: systematic review and meta-analysis
2010
Ginkgo biloba for cognitive impairment and dementia
2007
Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
2007
The projected effect of risk factor reduction on Alzheimer's disease prevalence
2011 Standout
Free amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjects
2006
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment
2004
RAGE Mediates a Novel Proinflammatory Axis
1999 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Knowing Where Things Are: Parahippocampal Involvement in Encoding Object Locations in Virtual Large-Scale Space
1998 StandoutNobel
Ginkgo biloba for cognitive impairment and dementia
2009
Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
2013
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
2009 Standout
In vivo cerebrovascular actions of amyloid β-peptides and the protective effect of conjugated estrogens
2003
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]
2001 Standout
The Treatment of Alzheimer Disease
2008
Complementary and Alternative Medicines for Alzheimer's Disease
1998
Ginkgo biloba for Dementia
1999
Plasma tau in Alzheimer disease
2016 StandoutNobel
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Presence of parieto‐temporal symptomatology distinguishes early and late onset Alzheimer's disease
1991
The MoCA
2010 Standout
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
2017
Diabetes mellitus and the risk of dementia
1999 Standout
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Syndromes majeurs de l'hémisphère mineur
2005
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
2010
Electroencephalogram in the dementia workup
2005
Works of Ralf Ihl being referenced
Topography of the quantitative electroencephalogram in dementia of the alzheimer type: Relation to severity of dementia
1991
Electrophysiological correlates of emotional and structural face processing in humans
2000
Differential validity of psychometric tests in dementia of the Alzheimer type
1992
Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type
1997
Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG
1991
Dementia of the alzheimer type: Effects on the spontaneous EEG described by dipole sources
1993
Event-Related Potentials and Psychopharmacology
1994
Electrical brain activity and cerebral blood flow in dementia of the Alzheimer type
1989
Staging in dementia of the alzheimer type: Topography of electrical brain activity reflects the severity of the disease
1989
Stage-dependent reductions of regional cerebral blood flow measured by HMPAO-SPECT in dementia of Alzheimer type
1989
EEG and the Test for the Early Detection of Dementia with Discrimination from Depression (TE4D): a validation study
2004
Alzheimer’s Disease Assessment Scale: Reliability and Validity in a Multicenter Clinical Trial
1997
Effects of Ginkgo biloba extract EGb 761®in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials
2013
Segmentation of the Spontaneous EEG in Dementia of the Alzheimer Type
1993
Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques.
1996
Efficacy and Tolerability of a Once Daily Formulation of Ginkgo biloba Extract EGb 761® in Alzheimer's Disease and Vascular Dementia: Results from a Randomised Controlled Trial
2011
Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial
2009
691 Selective binding of soluble Aβ1–40 and Aβ1–42 to a subset of senile plaques
1996
Effects of 3 months treatment with tenilsetam in patients suffering from dementia of Alzheimer type (DAT)
1989
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®
2019